SEC Form 5 · accession 0001209191-17-014932
AERIE PHARMACEUTICALS INC · AERI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas A Mitro
Officer — President and COO
Period of report
Dec 31, 2016
Accepted (ET)
Feb 27, 2017 · 6:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001337553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2016 | F | 1,300 | $16.34 | D | 27,450 | D |
Table II — derivative securities
No Table II lines on this filing.